| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |